FDA approves Axogen's nerve repair graft

Reuters
Dec 04, 2025
FDA approves Axogen's nerve repair graft

Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's AXGN.O nerve repair graft, the health regulator said on Wednesday.

(Reporting by Sriparna Roy, Padmanabhan Ananthan and Puyaan Singh in Bengaluru; Editing by Sherry Jacob-Phillips)

((Sriparna.Roy@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10